To include your compound in the COVID-19 Resource Center, submit it here.

French group outlines first-in-man trial precautions

A special committee created by the French National Agency for Medicines and Health Products Safety (ANSM) made initial recommendations for first-in-man trials following a death and several hospitalizations of healthy volunteers in a Phase

Read the full 343 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE